The programme which seeks to boost innovation in critical impact...
Category:
Non-Life
Latest
“Reliance Capital asks for extra 10 days for Hinduja group asset transfer”
The deadline for the transfer of Reliance Capital's asset to Aasia...
EU finalises investment fund labels to combat greenwashing
The European Securities and Markets Authority (ESMA) said a fund...
Skyrocketing liability insurance rates for SPACs
. Coverage of about $10 million to indemnify a blank-check company’s directors and officers now costs more than $1 million on average, according to a lawyer who works on SPAC deals. That’s up from $250,000 to $300,000 a year ago.
Rajasthan launches health insurance scheme for all claims it to be a first
The state began the registration for Chiranjeevi Health Insurance Scheme, announced by Chief Minister Ashok Gehlot in the state budget 2021-22.
“Rajasthan has become the first state in the country, where each family will get health insurance of Rs 5 lakh each year. People can get registered and be assured of cashless treatment,” Gehlot claimed in a tweet
No deaths reported, reduced severity: RML director on people contracting Covid after second vaccine dose
“So this is the kind of benefit which this vaccine is giving. We have not seen that those who got vaccinated and contracted the disease died. It doesn’t take a severe form in those who got vaccinated. We should grab the earliest opportunity to get vaccinated,” Director and Medical Superintendent, RML Hospital Dr Rana Anil Kumar Singh said .
Study reveals increased rates of organ damage after discharge from hospital with Covid-19
Although Covid-19 is most well known for causing serious respiratory problems, it can affect other organs and systems within the body, including the heart, kidneys, and liver.
Several unexplained symptoms that continue for more than 12 weeks after Covid-19 are said to be part of a post-Covid syndrome (also known as “long Covid”), but the long term pattern of organ damage after infection is still unclear.
Govt proposes to establish alternate funding, increase assistance in new Rare Disease Policy Draft
Noting that India has close to 50-100 million people affected by rare diseases or disorders, the policy report said almost 80 per cent of these rare condition patients are children and a leading cause for most of them not reaching adulthood is due to the high morbidity and mortality rates of these life-threatening diseases.
81,466 new COVID-19 cases reported, ‘second wave’ sweeps India
“New infections will turn into a “full-blown crisis” if people don’t take guard,” said Dr Randeep Guleria, director of All India Institute of Medical Sciences in Delhi, as saying.
Suez Canal to seek over $1bn compensation for losses caused by stuck ship
The SCA chairman explained that the compensation demanded by the authority is not only for the financial losses caused by six-day navigation suspension, but includes the expenses of using dredgers and tugboats and the physical damage caused during the salvage process.
Egypt resumed navigation in the canal several hours after the Ever Given was freed and re-floated on Monday, after which many of the 422 ships that have been kept waiting started to cross the waterway.
WHO experts say Chinese jabs show ‘safety’, but data lacking
The UN health agency’s Strategic Advisory Group of Experts on Immunization (SAGE) said it had reviewed the data provided so far, and that both vaccines “demonstrated safety and good efficacy against symptomatic Covid-19 disease”.
However, it warned, “both vaccines lacked data in older age groups and in persons with co-morbidities,” meaning other medical conditions.
India’s on its way to become the world’s pharmaceutical hub
At present, India is the largest provider of generic drugs globally. Indian pharma companies cater to over half of the global demand for various vaccines, along with 40 per cent of generic drugs demand in the US.
Notably, data from container logistics company Maersk showed that among the refrigerated cargo, pharmaceuticals export out of India rose steeply during 2020, with Q4 alone recording 47 per cent higher volumes as compared to the same period in 2019.
COVID-19: India records 72,330 new cases, highest single day rise
Registering a steady increase for the 22nd day in row, the active cases have increased to 5,84,055 comprising 4.78 per cent of the total infections, while the recovery rate has further dropped to 93.89 per cent, the data stated.